33 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
with the Proposed Transaction, RepliCel will also submit an application with the TSX Venture Exchange ("TSXV") and seek minority shareholder approval … in accordance with Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), as further
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Exchange ("TSXV") and seek minority shareholder approval for a voluntary delisting of RepliCel's common shares from the facilities of the TSXV … by Andrew Schutte for common shares held either directly or indirectly in accordance with Multilateral Instrument 61-101 - Protection of Minority
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
to be “related parties” of the Company within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special … on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(a) of MI 61-101
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
of Minority Security Holders in Special Transactions (“MI 61-101”) and each extension is considered to be a “related party transaction” within the meaning … ) as the Company’s shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
25 Oct 22
Current report (foreign)
12:27pm
participation by insiders in the Offering will constitute a related party transaction under Multilateral Instrument 61-101 - Protection of Minority Security … Holders in Special Transactions (“MI 61-101”) but is expected to be exempt from the formal valuation and minority shareholder approval requirements
6-K
EX-99.1
ujpq1a
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.4
k2pancdq oryst
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.5
yrfxxt2xxhg gm
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.3
2r4n5ku
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.2
16kmk0cb5v
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
ccc8n99w 0zjhwss0xy
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.2
a4wfqz
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.1
9yadckee
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.8
k0rebk0mu
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.7
e8d6csth9eg2kz8bni
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
mre6waopb5dx 4f
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
hza6c
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.1
wip8u 2i1t
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.1
5ca0a qat52994vik
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
6s2l0jp
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm